Salvage Radioligand Therapy with Repeated Cycles of (177)Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer with Diffuse Bone Marrow Involvement

SIMPLE SUMMARY: Metastatic castration-resistant prostate cancer (mCRPC) with extensive spread to the bone marrow is an incurable stage of disease associated with a poor prognosis and a high risk of impaired blood cell formation. Therapeutic options prolonging survival are limited and may result in s...

Descripción completa

Detalles Bibliográficos
Autores principales: Groener, Daniel, Baumgarten, Justus, Haefele, Sebastian, Happel, Christian, Klimek, Konrad, Mader, Nicolai, Nguyen Ngoc, Christina, Tselis, Nikolaos, Chun, Felix K. H., Grünwald, Frank, Sabet, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393804/
https://www.ncbi.nlm.nih.gov/pubmed/34439172
http://dx.doi.org/10.3390/cancers13164017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393804/
https://www.ncbi.nlm.nih.gov/pubmed/34439172
http://dx.doi.org/10.3390/cancers13164017

Ejemplares similares